Introduction
============

When infants exhibiting fever and no clear source of infection visit the Emergency Department (ED) or outpatient department (OPD), doctors must diagnose serious bacterial infection (SBI) as soon as possible and determine appropriate next steps. Infants younger than 3 months have the highest risk of SBI such as bacterial meningitis, bacteremia, and urinary tract infection (UTI). Infants between 1 and 3 months of age presenting with fever for unknown reasons are reported to have SBI rates of up to 9% \[[@b1-kjp-2017-06170]-[@b5-kjp-2017-06170]\]. In many studies, the procalcitonin (PCT) test is reported to be superior to other tests in predicting SBI in children \[[@b4-kjp-2017-06170],[@b6-kjp-2017-06170]-[@b12-kjp-2017-06170]\]. However, some reports indicate that it is no different from other tests \[[@b13-kjp-2017-06170]-[@b17-kjp-2017-06170]\].

In this study, we investigated if the PCT test is superior to testing for other biomarkers in predicting SBI in febrile infants with no clear source of infection. In addition, we investigated if the PCT test could better predict SBI when combined with tests for other biomarkers. We focused on infants between 1 and 3 months of age and reviewed their medical records for our assessments.

Materials and methods
=====================

1. Data collection, study setting, and definitions
--------------------------------------------------

We analyzed the medical records of 336 infant patients who were between 1 and 3 months of age, presented with fever with no clear source of infection, and visited the ED or OPD of Samsung Changwon Hospital from May 2015 to February 2017. We collected the following clinical data from the medical records: patient age, sex, birth history, etiology of fever, duration of fever at home, final diagnosis, highest temperature of fever (℃), PCT level, C-reactive protein (CRP) level, white blood cell (WBC) count, absolute neutrophil count (ANC), platelet (PLT) count, and results from blood, urine, and cerebrospinal fluid (CSF) cultures. Body temperature measured as 38℃ or higher was defined as fever.

We classified patients into two groups: SBI and non-SBI. In this study, SBI group was defined as (1) bacteremia with pathogenic causative organism grown in blood culture; (2) bacterial meningitis with pathological causative organism grown in CSF culture; or (3) UTI with pyuria (WBC\>5/high power field) and a single pathologic agent grown to more than 100,000 colony-forming units/mL in urine collected in a urine bag. Meningitis was defined as the meningism without altered consciousness, with CSF WBC ≥5/μL \[[@b18-kjp-2017-06170]\]. We had excluded the following bacteria from the bacteremia group by considering them as a skin flora (e.g., Coagulase negative staphylococci, *Bacillus* species, viridans streptococci, *Micrococcus* species) \[[@b19-kjp-2017-06170]\]. We defined non-SBI as proven viral infection, pyuria without bacterial growth on urine culture, meningitis without bacterial growth on CSF culture, respiratory infection or enteritis caused by either virus or bacteria, or fever without localized signs. We excluded Kawasaki disease in this study. The cutoff values were defined as PCT≥0.5 ng/mL, CRP ≥0.5 mg/dL, WBC\>19,000/μL, ANC\>1,300/μL, and PLT≤400×10^3^/μL, as previous study \[[@b6-kjp-2017-06170]\].

2. Statistical analysis
-----------------------

Continuous variables were expressed as mean±standard deviation. The independent *t* test and Mann-Whitney *U* test were used when comparing definitive SBI and non-SBI. Categorical variables were expressed as number (%), and either Pearson chi-square test or Fisher exact test was used for comparisons between groups. Sensitivity, specificity, positive predictive value, negative predictive value (NPV), accuracy, and area under the curves (AUCs) for biomarkers of SBI were calculated and compared. The accuracy is the proportion of true results (both true positives and true negatives) among the total number of cases examined. All analyses were conducted using Stata ver. 14.0 (Stata Corporation, College Station, TX, USA) and R 3.3.0 (R Foundation for Statistical Computing, Vienna, Austria; <http://www.R-project.org>) at a significance level of 0.05.

3. Ethics statement
-------------------

Ethical approval for this retrospective study was obtained from the Institutional Review Board of Samsung Changwon Hospital and informed consent was waived (approval number: SCMC2017-08-009).

Results
=======

We analyzed the medical record of 336 febrile infants between 1 and 3 months of age with no clear source of infection. Of the 336 febrile infants, 212 (63.1%) were male. Mean age at diagnosis was 59.5±24.5 days, gestational age was 38.8±1.3 weeks, and birth weight was 3,200±431 g. Type of delivery of SBI group did not differ from that of non-SBI group (cesarean section 50.5% vs. vaginal delivery 49.5%, *P*=0.659). However, the maximal body temperature of SBI group (39.0℃±0.5℃) was higher than that of non-SBI (38.6℃±0.5℃, *P*\<0.05). Ninety-five infants (28.3%) visited the hospital OPD and 241 (71.7%) visited the ER. Three hundred eight infants (91.7%) were admitted. The mean length of stay was 5.7±2.6 days. The onset of fever until arrival at the hospital was clearly noted in 191 patients. Of 191 patients, the mean duration of fever at home was 6.3±6.8 hours. Among the 336 cases, 38 (11.3%) were classified as definitive SBI. Of the 38 SBI patients, 3 patients were UTI sepsis caused by *Escherichia coli*, 1 patient was meningitis caused by Streptococcus agalactiae, and 34 patients were UTI ([Table 1](#t1-kjp-2017-06170){ref-type="table"}). Of the 34 patients of UTI, *E. coli* was the most commonly found pathogen, appearing in 33 cases; *S. agalactiae* was found in 1 case. There were no cases of definitive SBI with complication.

Mean laboratory values in SBI patients were PCT 6.4±11.9 ng/mL, CRP 3.8±2.6 mg/dL, WBC 12,882±6,568/μL, ANC 6,984±4,675/μL, and PLT 382.5±102.1×10^3^/μL. In comparison, the mean values in the non-SBI group were PCT 0.3±1.2 ng/mL, CRP 1.3±1.6 mg/dL, WBC 11,591±5,299/μL, ANC 4,888±3,661/μL, and PLT 397.5±121.1×10^3^/μL. There were significant differences in PCT, CRP, and ANC between SBI and non-SBI groups (*P*\<0.001) ([Table 2](#t2-kjp-2017-06170){ref-type="table"}).

The sensitivity of the SBI group was PCT 43.6%, CRP 92.3%, WBC 15.4%, ANC 97.4%, and PLT 51.3%. As well, the specificity of the SBI group was PCT 92.6%, CRP 25.3%, WBC 91.9%, ANC 5.1%, and PLT 52.2%.

However, the accuracy of the SBI group was 86.9% for PCT followed by 83.0% for WBC. If combined the biomarkers, PCT+WBC was revealed as the highest specificity and accuracy (98.3% and 88.1%), followed by PCT+CRP (93.6% and 87.2%) and PCT+ANC (92.9% and 86.9%, [Table 3](#t3-kjp-2017-06170){ref-type="table"}).

Predicted AUCs on receiver operating characteristic (ROC) curve were 77.0% for PCT and 80.8% for CRP, indicating that PCT and CRP were not different. The AUCs for biomarker combinations were 85.4% for PCT+CRP, 77.2% for PCT+WBC, 81.3% for PCT+ANC, 80.1% for CRP+WBC, and 81.6% for CRP+ANC. The highest AUC was confirmed as combination with PCT and CRP whether single biomarker or two combined biomarkers ([Fig. 1](#f1-kjp-2017-06170){ref-type="fig"}). The cutoff values on our ROC curve were confirmed as PCT 0.5 ng/mL, CRP 0.49 mg/dL, WBC 19,500/μL, ANC 1,300/μL, and PLT 400.5×10^3^/μL.

Discussion
==========

The probability of SBI without an apparent source is reported to be up to 12% for infants less than 28 days old and up to 9% for infants between 1 and 3 months of age \[[@b4-kjp-2017-06170]\]. Decades of research and debate have been dedicated not only to determining the likelihood of SBI causing fever in infant, but also to establishing treatment guidelines for such instances. Clinical examination alone is not sufficient to exclude SBI as a diagnosis. The Philadelphia and Rochester Criteria in combination with laboratory screening test results are used to assess SBI in patients. Sensitivity is reported to be 98% for the Philadelphia Criteria and 92% for the Rochester; reported NPVs are 97.1% and 97.3%, respectively \[[@b20-kjp-2017-06170],[@b21-kjp-2017-06170]\]. However, because accurately determining SBI in febrile infants is difficult, testing for several clinical biomarkers is used in conjunction with routine laboratory evaluation and clinical suspicion. The additional biomarker tests include those of peripheral WBC count, ANC, and CRP, which have sensitivities ranging from 45 to 79% and specificities ranging from 78% to 79% \[[@b4-kjp-2017-06170]\].

In 1993, Assicot et al. (quoted from \[[@b22-kjp-2017-06170]\]) reported that patients with SBI had high serum concentration of PCT, a calcitonin peptide without hormonal function. During infection or inflammation, plasma PCT concentration is known to both increases and return to normal more rapidly than CRP level \[[@b23-kjp-2017-06170]\]. PCT level was also observed to increase faster than CRP level 6 hours after the onset of severe inflammatory response syndrome \[[@b24-kjp-2017-06170]\]. For these reasons, the PCT test is considered a useful tool in early diagnosis of infection or inflammations. Other studies have investigated whether PCT is a useful biomarker to distinguish between viral infection and SBI. PCT was found to distinguish between bacterial and viral meningitis \[[@b8-kjp-2017-06170],[@b25-kjp-2017-06170],[@b26-kjp-2017-06170]\] and to identify SBI in infants more accurately than classic screening tests \[[@b6-kjp-2017-06170]\]. However, one report noted that PCT level might not be reliable in diagnosing bacterial meningitis after neurosurgery \[[@b16-kjp-2017-06170]\]. Another report found that serum PCT concentration is not a good indicator of bacterial ventriculoperitoneal shunt infection \[[@b17-kjp-2017-06170]\]. In pediatric patients visiting emergency departments or primary care, PCT testing was found to be superior to measuring WBC count, but similar to measuring CRP \[[@b15-kjp-2017-06170]\].

Several Korean studies have focused on PCT. Hur et al. \[[@b27-kjp-2017-06170]\] performed the PCT and CRP simultaneously on single blood samples from 1,270 patients with blood culture-positive sepsis. They reported that the diagnostic utility of the PCT was superior to evaluation of CRP level. However, in diagnosing neonatal bacterial infection, the PCT was found to be more expensive, with comparably acceptable specificity and similar or better sensitivity than the CPR \[[@b28-kjp-2017-06170]\]. Serum PCT level has been reported as a highly effective early diagnostic marker for neonatal bacterial infection, but is not as reliable a marker as CRP \[[@b29-kjp-2017-06170],[@b30-kjp-2017-06170]\]. Kim et al. \[[@b31-kjp-2017-06170]\] reported that there is no diagnostic value in measuring serum PCT concentration determine bacterial infection in febrile infants 6 months of age or younger. Yang et al. \[[@b32-kjp-2017-06170]\] reported similar sensitivities and specificities for serum CRP and serum PCT in diagnosing acute pyelonephritis (APN) in infants 12 months of age or younger. However, the sensitivity and specificity for APN diagnosis increased when PCT was combined with CRP and erythrocyte sedimentation rate.

In this study, sex and age at diagnosis in SBI group differed from those of non-SBI group because of large percentage of UTI or UTI sepsis in SBI group. Of 38 SBI patients, 34 had UTI and 3 had UTI sepsis. 76.5% of UTI group and 66.6% of bacteremia were 61--90 days old infants. Also, UTI were frequently diagnosed in male in infants.

This study had some limitations. First, we could not represent the entire infant population in Korea when assessing SBI, because this study was conducted using medical records from a single hospital. Second, determining the severity of SBI was difficult because few were found to have sepsis and meningitis among the definitive SBI patients. Third, we collected urine using urine bags rather than catheterization, increasing the likelihood of contamination.

Even with these limitations, our study offers a significant comparative analysis of biomarkers that can predict SBI in infants between 1 and 3 months of age who are vulnerable to infection and who visit the pediatric ED with fever.

In conclusion, PCT was shown as lower sensitivity than CRP, but higher specificity and accuracy than CRP for identifying SBI in febrile infants between 1 and 3 months of age. A combination of PCT and CRP showed the highest AUC than the other combination of biomarkers. Therefore, we suggested the predictor of SBIs for PCT or combination of PCT and CRP which were more accurate and specific biomarker to rule out the SBI.

No potential conflict of interest relevant to this article was reported.

![(A) Receiver operating characteristic curves of single biomarkers for serious bacterial infection. (B) Receiver operating characteristic curves of combined biomarkers. PCT, procalcitonin; CRP, C-reactive protein; WBC, white blood cell; ANC, absolute neutrophil count; PLT, platelet.](kjp-2017-06170f1){#f1-kjp-2017-06170}

###### 

Comparison of demographics between SBI and non-SBI groups (n=336)

  Variable                                Total (n=336)   Non-SBI (n=298)   SBI (n=38)   *P* value
  --------------------------------------- --------------- ----------------- ------------ -----------
  Sex                                                                                    0.001
   Male                                   212 (63.1)      179 (60.1)        33 (86.82)   
   Female                                 124 (36.9)      119 (39.9)        5 (13.2)     
  Age at diagnosis (day)                  59.5±24.5       58.4±24.6         68.1±22.5    0.015
  Gestational age (wk) (n=326)            38.8±1.3        38.7±1.3          39.2±1.2     0.061
   Pre term                               21 (6.2)        21 (7.0)          0 (0)        0.111
   Full term                              298 (88.7)      263 (88.3)        35 (92.1)    
   Post term                              17 (5.1)        14 (4.7)          3 (7.9)      
  Birth weight (g) (n=325)                3,200±431       3,185±432         3,320±415    0.091
   \<2,500                                11 (3.3)        11 (3.7)          0 (0)        0.606
   2,500--4,000                           302 (89.9)      267 (89.6)        35 (92.1)    
   ≥4,000                                 23 (6.8)        20 (6.7)          3 (7.9)      
  Type of delivery (n=325)                                                               0.416
   Cesarean section                       164 (50.5)      143 (49.7)        21 (57.8)    
   Vaginal delivery                       161 (49.5)      145 (50.3)        16 (43.2)    
  Diagnosis                                                                              \<0.001
   Fever without localized signs          167 (49.7)      167 (56.0)        0 (0)        
   Bacteremia                             3 (0.9)         0 (0)             3 (7.9)      
   Meningitis                             49 (14.6)       48 (16.1)         1 (2.6)      
   Respiratory                            65 (19.3)       65 (21.8)         0 (0)        
   Gastrointestinal                       14 (4.2)        14 (4.7)          0 (0)        
   Urinary tract infection                34 (10.1)       0 (0)             34 (89.5)    
   Etc.                                   4 (1.2)         4 (1.3)           0 (0)        
  Maximal body temperature (ºC) (n=331)   38.6±0.5        38.6±0.5          39.0±0.5     \<0.001
  Fever duration at home (hr) (n=191)     6.3±6.8         6.1±6.8           7.7±6.9      0.336
  Admission                                                                              0.343
   No                                     28 (8.3)        27 (9.1)          1 (2.6)      
   Yes                                    308 (91.7)      271 (90.9)        37 (97.4)    
  Length of stay (day) (n=308)            5.7±2.6         5.6±2.4           6.1±3.9      0.651

Values are presented as number (%) or mean±standard deviation.

SBI, serious bacterial infection.

###### 

Comparison of laboratory characteristics between SBI and non-SBI groups (n=336)

  Variable                          Total (n=336)   Non-SBI (n=298)   SBI (n=38)     *P* value
  --------------------------------- --------------- ----------------- -------------- -----------
  Procalcitonin (ng/mL)             1.0±4.6         0.3±1.2           6.4±11.9       \<0.001
   \<0.5                            297 (88.4)      276 (92.6)        21 (55.3)      \<0.001
   ≥0.5                             39 (11.6)       22 (7.4)          17 (44.7)      
  C-reactive protein (mg/dL)        1.6±1.9         1.3±1.6           3.8±2.6        \<0.001
   \<0.5                            78 (23.2)       75 (25.2)         3 (7.9)        0.018
   ≥0.5                             258 (76.8)      223 (74.8)        35 (92.1)      
  White blood cell (/μL)            11,737±5,461    11,591±5,299      12,882±6,568   0.185
   ≤19,000                          306 (91.1)      274 (92.0)        32 (84.2)      0.115
   \>19,000                         30 (8.9)        24 (8.1)          6 (15.8)       
  Absolute neutrophil count (/μL)   5,125±3,839     4,888±3,661       6,984±4,675    \<0.001
   ≤1,300                           16 (4.8)        15 (5.0)          1 (2.6)        \>0.999
   \>1,300                          320 (95.2)      283 (95.0)        37 (97.4)      
  Platelet (×10³/μL)                395.8±119.1     397.5±121.1       382.5±102.1    0.708
   ≤400                             174 (51.8)      156 (52.3)        18 (47.4)      0.563
   \>400                            162 (48.2)      142 (47.7)        20 (52.6)      

Values are presented as mean±standard deviation or number (%).

SBI, serious bacterial infection.

###### 

Sensitivity, specificity, positive predictive value, negative predictive value, accuracy for definite SBI

  Variable                               Sensitivity (%)     Specificity (%)     PPV (%)             NPV (%)             Accuracy^[\*](#tfn1-kjp-2017-06170){ref-type="table-fn"}^ (%)
  -------------------------------------- ------------------- ------------------- ------------------- ------------------- ---------------------------------------------------------------
  Procalcitonin (0.5 ng/mL)              43.6 (27.8--60.4)   92.6 (89.0--95.3)   43.6 (27.8--60.4)   92.6 (89.0--95.3)   86.9 (82.8--90.3)
  C-reactive protein (0.5 mg/dL)         92.3 (79.1--98.4)   25.3 (20.4--30.6)   14.0 (10.0--18.8)   96.2 (89.2--99.2)   33.0 (28.0--38.3)
  White blood cell (19,000/μL)           15.4 (5.9--30.5)    91.9 (88.2--94.8)   20.0 (7.7--38.6)    89.2 (85.2--94.5)   83.0 (78.6--86.9)
  Absolute neutrophil count (1,300/μL)   97.4 (86.5--99.9)   5.1 (2.9--8.2)      11.9 (8.5--15.9)    93.8 (69.8--99.8)   15.8 (12.0--20.1)
  Platelet (400×10³/μL)                  51.3 (34.8--67.6)   52.2 (46.3--58.0)   12.3 (7.7--18.4)    89.1 (83.5--93.3)   52.1 (46.6--57.5)
  Combination                                                                                                            
   PCT+CRP                               38.5 (23.4--55.4)   93.6 (90.2--96.1)   44.1 (27.2--62.1)   92.1 (88.4--94.8)   87.2 (83.2--90.6)
   PCT+WBC                               10.3 (2.9--24.2)    98.3 (96.1--99.5)   44.4 (13.7--78.8)   89.3 (85.4--92.4)   88.1 (84.1--91.4)
   PCT+ANC                               41.0 (25.6--57.9)   92.9 (89.4--95.6)   43.2 (27.1--60.5)   92.3 (88.7--95.1)   86.9 (82.8--90.3)
   CRP+WBC                               15.4 (5.9--30.5)    91.9 (88.2--94.8)   20.0 (7.7--38.6)    89.2 (85.2--92.5)   83.0 (78.6--86.9)
   CRP+ANC                               89.7 (75.8--97.1)   28.6 (23.5--34.1)   14.2 (10.1--19.2)   95.5 (88.9--98.8)   35.7 (30.6--41.1)

SBI, serious bacterial infection; PPV, positive predictive value; NPV, negative predictive value; PCT, procalcitonin; CRP, C-reactive protein; WBC, white blood cell; ANC, absolute neutrophil count.

Accuracy=(number of true positive cases+true negative cases)/total number of cases.
